The World Health Organization (WHO) has finally made its recommendations on using glucagon-like peptide-1 (GLP-1) therapeutics for weight loss, though it remains to be seen whether it changes their status for prescribing or their price.

The number of adults living with diabetes worldwide has now surpassed 800 million, and the World Health Organization calls Type 2 diabetes an epidemic. But new science is giving hope.

The World Health Organization (WHO) issued a medical product alert Thursday warning that fake versions of medications used for diabetes and obesity, like Ozempic, have been detected in some countries. The warning said three fake batches of semaglutide, a ...

(NEW YORK) — The number of people who suffer from diabetes could double over the next two decades, the World Health Organization said Thursday, sending a warning about the illness on World Health Day. There are currently 422 million people with type 1 ...

Dr. Bianca Hemmingsen is Technical Lead – Diabetes, Department of Noncommunicable Diseases and Mental Health, World Health Organization (WHO); Ms. Sanjana Marpadga is a Technical Officer – Diabetes, Department of Noncommunicable Diseases and Mental ...

People around the world eat too much sugar. When the body is unable to process sugar effectively, leading to excess glucose in the blood, this can result in diabetes. According to the World Health Organization, diabetes became the ninth leading cause of ...

olastrocel is an allogeneic, off-the-shelf cellular therapeutic candidate derived from perinatal tissue and developed under the Company’s AlloStem® platform. It is in clinical development for:

(BPT) - Diabetes is one of the most common chronic health conditions worldwide. 1 Daily management is tough, but one of the biggest challenges for those living with diabetes is confronting stigma, judgment and misconceptions from people who don't share the ...